Table 2 Clinical characteristics of HIV-infected women (n=2,501)
From: Cervical cancer risk factors among HIV-infected Nigerian women
| n (%) | Missing (%) | |
|---|---|---|
| BMI (kg/m2) | 1840 (73.6) | |
| <18.5 | 46 (7) | |
| 18.5–24.9 | 401 (61) | |
| 25–29.9 | 49 (7) | |
| ≥30 | 165 (25) | |
| Vaginal wall abnormality | 0 (0) | |
| None | 2241 (90) | |
| Other1 | 260 (10) | |
| VIA | 0 (0) | |
| Negative | 2344 (94) | |
| Positive | 155 (6) | |
| Invasive cancer | 2 (0) | |
| Last CD4 count (per mm3) | 365 (14.6) | |
| <300 | 490 (23) | |
| 300–<450 | 560 (26) | |
| 450–<650 | 592 (28) | |
| ≥650 | 494 (23) | |
| WHO stage | 1118 (44.7) | |
| Stage 1 | 1185 (86) | |
| Stage 2 | 104 (7) | |
| Stage 3 | 84 (6) | |
| Stage 4 | 10 (1) | |
| ART regimen currently on2 | 1008 (40) | |
| TDF-containing ART3 | 778 (52) | |
| ZDV-containing ART4 | 600 (40) | |
| d4T-containing ART5 | 115 (8) |